Arrhythmogenic actions of antiarrhythmic drugs (original) (raw)
Channel specificity in antiarrhythmic drug action. Mechanism of potassium channel block and its role in suppressing and aggravating cardiac arrhythmias
Frank Starmer
Circulation, 1990
View PDFchevron_right
The arrhythmogenicity of antiarrhythmic agents*1
Victor Torres
American Heart Journal, 1985
View PDFchevron_right
The arrhythmogenicity of antiarrhythmic agents
David Flowers
American Heart Journal, 1985
View PDFchevron_right
Electropharmacology of antiarrhythmic drugs
Andrew Wit
American Heart Journal, 1983
View PDFchevron_right
Overview of the clinical pharmacology of antiarrhythmic drugs
Alessandro Capucci, Giovanni Villani
The American Journal of Cardiology, 1988
View PDFchevron_right
Clinical types of proarrhythmic response to antiarrhythmic drugs
John T. Bigger
The American Journal of Cardiology, 1987
View PDFchevron_right
Effects of class I antiarrhythmic drugs on the digitalis-induced triggered activity arrhythmia model: a rationale for the short-term use of class I drugs against triggered arrhythmias
Atsushi Sugiyama
Heart and Vessels, 2004
View PDFchevron_right
Clinical Pharmacology of Antiarrhythmic Drugs
Klaus Romero
Drugs & Aging, 1998
View PDFchevron_right
Clinical pharmacology of antiarrhythmic drugs: Variability of metabolism and dose requirements
Ferenc Follath
Journal of Cardiovascular Pharmacology
View PDFchevron_right
Pharmacotherapy of Cardiac Arrhythmias-Basic Science for Clinicians
Chinmay Patel
Pacing and Clinical Electrophysiology, 2009
View PDFchevron_right
Modification by hypoxia, hyperkalaemia and acidosis of the cardiac electrophysiological effects of a range of antiarrhythmic drugs
Davide Pacini
British Journal of Pharmacology, 1992
View PDFchevron_right
How antiarrhythmic drugs increase the rate of sudden cardiac death
Frank Starmer
International Journal of Bifurcation and Chaos, 2002
View PDFchevron_right
Importance of physico-chemical properties in determining the kinetics of the effects of Class I antiarrhythmic drugs on maximum rate of depolarization in guinea-pig ventricle
Terence Campbell
British Journal of Pharmacology, 1983
View PDFchevron_right
Comparative hemodynamics of antiarrhythmic drugs
Magdi Sami
Cardiovascular Drugs and Therapy, 1990
View PDFchevron_right
Aggravation of arrhythmia induced with antiarrhythmic drugs during electrophysiologic testing
Federico Lombardi
American Heart Journal, 1985
View PDFchevron_right
Drugs and trafficking of ion channels: a new pro-arrhythmic threat on the horizon?
Marcel Van Der Heyden
British Journal of Pharmacology, 2008
View PDFchevron_right
Drug-induced Inhibition and Trafficking Disruption of ion Channels: Pathogenesis of QT Abnormalities and Drug-induced Fatal Arrhythmias
Luigi Cubeddu
Current Cardiology Reviews
View PDFchevron_right
A proarrhythmic response to sodium channel blockade: modulation of the vulnerable period in guinea pig ventricular myocardium
Frank Starmer
PubMed, 1992
View PDFchevron_right
New drugs vs. old concepts: A fresh look at antiarrhythmics
J. Thireau
Pharmacology & Therapeutics, 2011
View PDFchevron_right
Use of calcium antagonists for cardiac arrhythmias
Koonlawee Nademanee
The American Journal of Cardiology, 1987
View PDFchevron_right
Assessment of drug-induced proarrhythmia: The importance of study design in the rabbit left ventricular wedge model
David J Gallacher
Journal of pharmacological and toxicological methods, 2016
View PDFchevron_right
Antiarrhythmic drug classifications and the clinician: A gambit in the land of chaos
John Camm
Clinical Cardiology, 1994
View PDFchevron_right
Proarrhythmic response to sodium channel blockade. Theoretical model and numerical experiments
Frank Starmer
Circulation, 1991
View PDFchevron_right
Effects of Drugs on Electrocardiogram: A Review.
Ijesrt Journal
International Journal of Engineering Sciences & Research Technology, 2014
View PDFchevron_right
New method for the assessment of drug-induced arrhythmia aggravation
Karl Wegscheider
The American Journal of Cardiology, 1988
View PDFchevron_right
Update on antiarrhythmic drug pharmacology
Christopher Huang
Journal of Cardiovascular Electrophysiology, 2020
View PDFchevron_right
Antiarrhythmic drug action. Blockade of the inward sodium current
Frank Starmer
Circulation Research, 1984
View PDFchevron_right
Upregulation of the rat cardiac sodium channel by in vivo treatment with a class I antiarrhythmic drug
M. Taouis
Journal of Clinical Investigation, 1991
View PDFchevron_right
Differentiating electrophysiological effects and cardiac safety of drugs based on the electrocardiogram: A blinded validation
Willi Suter
Heart Rhythm, 2012
View PDFchevron_right
Blockade of cardiac sodium channels by amitriptyline and diphenylhydantoin. Evidence for two use-dependent binding sites
Frank Starmer
Circulation Research, 1991
View PDFchevron_right
Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the ‘bad’ sodium current blockers
Karel Van Ammel
British Journal of Pharmacology, 2010
View PDFchevron_right
Allosteric Modulation of K v 11.1 (hERG) Channels Protects Against Drug-Induced Ventricular Arrhythmias
Jacobus Van Veldhoven
Circulation-arrhythmia and Electrophysiology, 2016
View PDFchevron_right
The antiarrhythmic actions of bisaramil and penticainide result from mixed cardiac ion channel blockade
Michael K Pugsley
Biomedicine & Pharmacotherapy, 2019
View PDFchevron_right
Sodium Channel Selectivity Filter Regulates Antiarrhythmic Drug Binding
Akihiko Sunami
Proceedings of the National Academy of Sciences of the United States of America, 1997
View PDFchevron_right
Combined effects of different class I antiarrhythmic agents on maximum rate of depolarization (V max ) of action potentials in guinea-gig papillary muscles
Akihiko Sunami
Cardiovascular Drugs and Therapy, 1991
View PDFchevron_right